Rare diseases
Investigational molecules
Locations
Back to Belgium294 clinical trials in Roeselare, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease
BelgiumStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
BelgiumA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
BelgiumRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
BelgiumZenagamtide for Weight Loss in Adults with Obesity
BelgiumA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
BelgiumPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
BelgiumA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
BelgiumA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
BelgiumA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
BelgiumA study to evaluate the effectiveness of epcoritamab in patients with Waldenström's macroglobulinemia that has returned or has not responded to previous treatments.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on bladder cancer, lung cancer, and various blood cancers. Studies evaluate novel combination therapies and targeted treatments.
Research includes innovative immunotherapy combinations and precision medicine approaches.
Clinical investigations targeting hypertriglyceridemia and obesity-related conditions, with emphasis on novel therapeutic approaches.
Studies focus on developing safer and more effective treatments for metabolic conditions.
Studies examining treatments for Alzheimer's disease and multiple sclerosis, with particular attention to innovative therapeutic approaches.
Research aims to improve quality of life and disease management for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
